Skip to content
RDL Network logo
Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study — Leila Motedayen Aval (2025) | RDL Network